Catalent Reveals ADVASEPT Lock Expansion at Interphex

New Jersey-based Catalent announced the expansion of its ADVASEPT Lock delivery technology during this month’s Interphex conference in New York. It is a stopper-less, glass- and needle-free vial for safe delivery of injectable medications.

It is available in 1, 3, and 5-milliliter container closures but may be custom-designed to meet specific brand or delivery needs.

Wheaton High Recovery Vial Study Available at Interphex

Wheaton, a provider of laboratory plastic and glass goods for life science and biopharmaceuticals, released a new white paper highlighting a discovery that use of its high recovery vials (HRV) provides a 99 percent residual waste reduction compared to traditional flat-bottom vials. The study will be available at Interphex on April 21 through April 23 in New York at booth #1412.

Interphex 2012

Interphex 2012 will be held at New York City’s Jacob K. Javits Center on May 1-3, 2012. Headlining this event will be a series of keynote presentations presented by leading subject matter experts.

No votes yet

The Latest in New Products

COC Vials

No votes yet

Don't Miss the Pharmapack Europe Conference

Plan now to visit Pharmapack Europe in Paris February 15-16. For more details on the event, visit Hope to see you stop by the PMP News booth!


15th February 2012

9.30: Opening Address
“From Mesopotamia to modern times, THINK DIFFERENT about INNOVATION,” Patrice Noailles, Président, Seillans Investissement, France

No votes yet

Calcium Gluconate Injection Recalled Because of Silicone Particles

One lot of Calcium Gluconate Injection, USP, 10%, 100 mL Pharmacy Bulk Package, has been recalled by American Regent because the vials may contain silicone particles, the company reported in a statement posted to FDA's Web site. The lot is #1006, Expiration Date: January 2013, NDC # 0517-3900-25. No other lots or sizes are involved.

Visible Particulates in Vials Prompt American Regent Recall

American Regent reports on FDA's Web site that the company is recalling Caffeine & Sodium Benzoate Injection, USP, 250 mg/mL, 2 mL Single Dose Vial, NDC # 0517-2502-10. The recall only affects lot #0084. No other lots of Caffeine & Sodium Benzoate Injection, USP are subject to this voluntary recall, the company reports.

The Latest in New Products

High-Resolution Registration Mark Sensor

No votes yet

Linda S. Mayer Appointed President and CEO of SCHOTT Corporation and SCHOTT North America, Inc.

SCHOTT North America Inc. appoints Linda S. Mayer to the office of president and CEO, making her the first woman to head the 2,800-employee strong North American operations of the specialty glass and materials technologies manufacturer. She succeeds former President and CEO Dr. Gerald Fine who became a director of SCHOTT Corp. and a member of the company’s North American Advisory Board in January.

Schott Pharmaceutical Packaging Adds More Facilities around the World

At Interphex this past week in New York City, Schott Pharmaceutical Packaging detailed its expanded worldwide production capacities in Argentina, Japan, and Russia.

Syndicate content